Finance
Results: 4741-4752 of 41723

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)

Universal Music Group N.V. to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025





